| Ms Meghan R Skakun, APN | |
|
130 S Bryn Mawr Ave, Bryn Mawr Hospital, Bryn Mawr, PA 19010-3121 | |
| (484) 337-4618 | |
| (484) 337-4661 |
| Full Name | Ms Meghan R Skakun |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 130 S Bryn Mawr Ave, Bryn Mawr, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033441563 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | RN611830 (Pennsylvania) | Secondary |
| 363L00000X | Nurse Practitioner | SPO10688 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Meghan R Skakun, APN 130 S Bryn Mawr Ave, Bryn Mawr Hospital, Bryn Mawr, PA 19010-3121 Ph: (484) 337-4618 | Ms Meghan R Skakun, APN 130 S Bryn Mawr Ave, Bryn Mawr Hospital, Bryn Mawr, PA 19010-3121 Ph: (484) 337-4618 |
News Archive
Acute kidney injury (AKI) occurred in nearly 20 percent of patients who underwent surgery with implantation of antibiotic-loaded "spacers" and intravenous (IV) antibiotics for the treatment of deep infections after total knee arthroplasty, reports a study in The Journal of Bone & Joint Surgery.
The Foundation for Biomedical Research (FBR) announced today the release of its new PSA, "Jen's Story 2," as part of its ResearchSaves national campaign. The 60-second spot reunites viewers with Jen, a real biomedical researcher who specializes in breast cancer research and is battling the disease herself.
ISTA Pharmaceuticals, Inc., today announced that it has initiated a Phase 3 clinical program of ISTA's proprietary formulation of REMURA (bromfenac ophthalmic solution for dry eye) for alleviating the signs and symptoms of dry eye disease. The Phase 3 efficacy studies are being conducted under a Special Protocol Assessment (SPA) agreed upon with the U.S. Food and Drug Administration (FDA).
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data from its RNAi therapeutic program for the treatment of hemophilia and rare bleeding disorders.
The overall survival rate from cancer now is lower in older adolescents and young adults with cancer than in younger children, in part because of a lack of access to clinical trials nationally for the older age group, according to a study by pediatric oncologists at Children's Hospital of Pittsburgh of UPMC.
› Verified 3 days ago
Mrs. Jodi Lynn Kanzinger, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 130 S Bryn Mawr Ave, Suite H321, Bryn Mawr, PA 19010 Phone: 484-337-4097 Fax: 484-337-4086 | |
Harriet Marie Mccarney, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1030 E Lancaster Ave, Bryn Mawr, PA 19010 Phone: 610-525-3225 Fax: 610-525-4932 | |
Jenna Walck, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 130 S Bryn Mawr Ave, Bryn Mawr, PA 19010 Phone: 484-337-3000 | |
Stephanie Nicole Libes, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 130 S Bryn Mawr Ave, Bryn Mawr, PA 19010 Phone: 215-662-3743 Fax: 215-349-5895 | |
Awilda Rodriguez, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 830 Old Lancaster Rd Ste 206, Bryn Mawr, PA 19010 Phone: 484-380-3094 | |
Rachel Melissa Goldstein, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 918 County Line Rd, Bryn Mawr, PA 19010 Phone: 610-525-6086 |